Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/−mice-Reference-Cited by-同舟云学术

Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E−/−mice

Published:2017-02-14 Issue:22 Volume:174 Page:4043-4054
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Petri Marcelo H¹,Laguna-Fernandez Andrés¹,Arnardottir Hildur¹,Wheelock Craig E²,Perretti Mauro³,Hansson Göran K¹,Bäck Magnus¹⁴

Affiliation:

1. Experimental Cardiovascular Research Group, Cardiovascular Medicine Unit, Center for Molecular Medicine, Department of Medicine; Karolinska Institutet; Stockholm Sweden

2. Department of Medical Biochemistry and Biophysics; Karlinska Institutet; Stockholm Sweden

3. William Harvey Research Institute, Barts and The London School of Medicine; Queen Mary University of London; London UK

4. Department of Cardiology; Karolinska University Hospital; Stockholm Sweden

Funder

Wellcome Trust

Stockholms Läns Landsting

Vetenskapsrådet

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13707/fullpdf

Reference36 articles.

1. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors;Alexander;Br J Pharmacol,2015

2. Anti-inflammatory therapies for atherosclerosis;Bäck;Nat Rev Cardiol,2015

3. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia;Bäck;Proc Natl Acad Sci U S A,2005

4. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7;Bäck;Br J Pharmacol,2014

5. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma;Barnig;Sci Transl Med,2013

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases;Circulation Research;2024-06-21

2. Inflammation and coronary microvascular disease: relationship, mechanism and treatment;Frontiers in Cardiovascular Medicine;2024-05-21

3. Targeting immune cell recruitment in atherosclerosis;Nature Reviews Cardiology;2024-04-25

4. Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis;Current Medicinal Chemistry;2024-03-19

5. Macrophage mediators and mechanisms in cardiovascular disease;The FASEB Journal;2024-01-26